Association of Connexin 32 with Prostate Volume and PSA Level in Prostatic Adenocarcinoma and Adenomyomatous Hyperplasia

Creative Commons License

ERDEM H., ÇIRAKOĞLU A., BENLİ E., ÇANKAYA S.

JOURNAL OF UROLOGICAL SURGERY, vol.7, no.2, pp.103-108, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.4274/jus.galenos2019.3042
  • Journal Name: JOURNAL OF UROLOGICAL SURGERY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.103-108
  • Keywords: Prostatic adenocarcinomas, Adenomyomatous hyperplasia, Prostate-specific antigen, Prostate volume, ANTIGEN, EXPRESSION, CANCER, PROGRESSION, CARCINOMA, PATHOLOGY, DENSITY, GENES, MOUSE, SERUM
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Objective: Prostate cancer (PC) is the second most common cancer in men in the world. PC is associated with many parameters. Connexins may also be prognostic parameters in this study, we aimed to evaluate Cx32 expression in prostatic adenocarcinomas (PCa) and adenomyomatous hyperplasia (AH). In addition, age, prostate-specific antigen (PSA) level, prostate volume (PV), Gleason score (GS) (and grade group) were also evaluated.